Rare lephants
Screener

Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 13, 2024 8-K
ARS May 10, 2024 ARS
PRE 14A May 10, 2024 PRE 14A
4 Apr 11, 2024 4
8-K/A Apr 2, 2024 8-K/A
10-K Apr 1, 2024 10-K
8-K Apr 1, 2024 8-K
8-K Mar 18, 2024 8-K
4 Mar 14, 2024 4
3 Mar 14, 2024 3
8-K Mar 12, 2024 8-K
4 Nov 17, 2023 FORM 4
4/A Nov 15, 2023 FORM 4/A
3 Nov 15, 2023 FORM 3
4 Nov 15, 2023 FORM 4
10-Q Nov 13, 2023 FORM 10-Q
8-K Nov 13, 2023 FORM 8-K
8-K Nov 9, 2023 FORM 8-K
3 Oct 16, 2023 FORM 3
8-K Oct 6, 2023 FORM 8-K
8-K Sep 28, 2023 FORM 8-K
8-K Aug 31, 2023 FORM 8-K
10-Q Aug 14, 2023 FORM 10-Q
8-K Aug 14, 2023 FORM 8-K
8-K Jul 13, 2023 FORM 8-K
← Newer Page 5 of 26 · 641 filings Older →